Work

In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity

Year: 2018

Type: article

Source: Cellular and Molecular Immunology

DOI: 10.1038/s41423-018-0087-y

Authors: Merylin Cottagiri, Maeva Nyandjo, Matthew Stephens, Joel J. Mantilla, Hirohisa Saito, Ian R. Mackay, Noel R. Rose, Dolores B. Njoku

Institutions: Johns Hopkins University, RIKEN, Monash University, Brigham and Women's Hospital, Harvard University

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: American Autoimmune Related Diseases Association

OpenAlex ID: W2883143502

FWCI: 0.967

Cites: 34

Cited by: 15

Related to: 10